AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field
In this AMA episode, Peter Attia discusses peptides, covering their evaluation, the differences between FDA-approved and gray-market options, and their potential future in medicine. He provides a framework for understanding peptide mechanisms, evidence, safety, and regulatory…